100215-29-0 ((2-Methyl-5-nitroimidazole)

CHEBI:181956;FT-0612958;2-Methyl-4(5)-nitroimidazole;EC 211-790-3;BCP32909;L-581490;Metronidazole impurity A;2-Methyl-5-nitro-1H-imidazole;UNII-24AG2WW15W;AKOS025394814;CS-W011149;Q27253838;Z1245636358;AS-10894;2-Methyl-5-nitroimidazole, British Pharmacopoeia (BP) Reference Standard;AKOS000294748;100215-29-0;696-23-1;AC-10807;SMR004703227;InChI=1/C4H5N3O2/c1-3-5-2-4(6-3)7(8)9/h2H,1H3,(H,5,6);Tinidazole impurity A, European Pharmacopoeia (EP) Reference Standard;1H-Imidazole, 2-methyl-4-nitro-;Menidazole, VETRANAL(TM), analytical standard;DTXSID2061010;AC-8195;PD055434;F1905-7036;2-METHYL-4-NITRO-1H-IMIDAZOLE;2-Methyl-5-nitroimidazole;RP 8532;2-Methyl-4(5)nitroimidazole;24AG2WW15W;FT-0612982;Menidazole;88054-22-2;2-methyl -5-nitroimidazole;FFYTTYVSDVWNMY-UHFFFAOYSA-;BCP32918;RP-8532;Tinidazole EP Impurity A;Ornidazole Impurity B;2-Methyl-5-nitroimidazole;5-nitro-2-methylimidazole;M0922;InChI=1/C4H5N3O2/c1-3-5-2-4(6-3)7(8)9/h2H,1H3,(H,5,6;AM20120266;TINIDAZOLE IMPURITY A [EP IMPURITY];2-methyl-4-nitro-3H-imidazole;METHYL-4-NITROIMIDAZOLE, 2-;AKOS015912419;EN300-21470;Imidazole, 2-methyl-5-nitro-;SR-01000945053-1;Imidazole, 2-methyl-4(or 5)-nitro-;AKOS000266160;METRONIDAZOLE BENZOATE IMPURITY B [EP IMPURITY];Tinidazole impurity A;EINECS 211-790-3;Imidazole, 2-methyl-4-nitro-;SB38360;A842456;W-109594;CHEMBL134454;SCHEMBL63215;NS00007865;SR-01000945053;Q-200303;1H-Imidazole, 2-methyl-5-nitro-;MFCD00005191;ORNIDAZOLE METABOLITE M1;2-Methyl-4(5)-nitroimidazole, 99%;Metronidazole impurity A, European Pharmacopoeia (EP) Reference Standard;2-Methyl-4-nitroimidazole;MLS006011386;

FFYTTYVSDVWNMY-UHFFFAOYSA-N

1S/C4H5N3O2/c1-3-5-2-4(6-3)7(8)9/h2H,1H3,(H,5,6)

[O-][N+](C1=CN=C(C)N1)=O

甲硝羟乙唑(灭滴灵)的中间体

用2-甲基咪唑以混酸硝化制得。